Spend less time thinking about diabetes and more time living your life. Personal, discreet and easy to use: find your Kaleido insulin pump.
Location: Netherlands
Employees: 51-200
Total raised: $85M
Investors 1
| Date | Name | Website |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.09.2025 | Series D | $85M | Invest-NL |
Mentions in press and media 15
| Date | Title | Description |
| 07.07.2026 | Could Insulin Patch Pumps Become the Future of Diabetes Care? Market Outlook Through 2034 | Managing diabetes is becoming increasingly technology-driven as healthcare providers shift from conventional insulin delivery methods toward connected and patient-friendly solutions. Among these innovations, insulin patch pumps are gaining ... |
| 08.01.2026 | ViCentra Raises $13M in Series D Extension Funding | ViCentra, a Utrecht, the Netherlands-based medical device company, raised $13M in Series D extension funding. Backers included ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech, alongside support from existing... |
| 31.10.2025 | GHO Capital Secures €2.5 Billion Fund, Dominating Global Healthcare Private Equity | GHO Capital secures over €2.5 billion for its fourth fund, GHO Capital IV LP. This monumental close positions GHO as Europe's largest healthcare-focused private equity firm, with total assets under management now approximately €9 billion. T... |
| 28.10.2025 | London-based GHO Capital boosts healthcare fund size by 25% to €2.5 billion | Global Healthcare Opportunities, the UK specialist investor in global healthcare, today announces the final close of its fourth fund, GHO Capital IV LP, raising over €2.5 billion of capital available to invest. Fund IV further diversifies G... |
| 07.10.2025 | Dutch men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through telehealth | The Amsterdam-based online clinic Fellos is scaling rapidly: the platform has raised over €2 million in growth capital from strategic investors, including a group of healthcare professionals, Dutch Operator Fund, and Capital Mills. The plat... |
| 06.09.2025 | ViCentra Secures $85 Million to Revolutionize Diabetes Care with Kaleido Patch Pump, Eyes U.S. Market | ViCentra, a European MedTech firm, raised $85 million in Series D funding. This capital will accelerate production and launch of its Kaleido 2 patch pump across Europe. It also prepares for critical U.S. market entry. Kaleido offers a uniqu... |
| 05.09.2025 | Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump | ViCentra, an Utrecht-based medical device company innovating insulin delivery for people with diabetes, announced the successful close of a €72.4 million Series D financing to accelerate manufacturing and launch the Kaleido 2 patch pump in ... |
| 05.09.2025 | ViCentra: $85 Million Raised To Expand Kaleido Patch Pump And Advance Global Diabetes Care | ViCentra, a European medical technology company focused on transforming insulin delivery for people living with diabetes, has announced the close of an $85 million Series D funding round. The round was led by Innovation Industries and inclu... |
| 03.09.2025 | ViCentra Raises $85M in Series D Funding | ViCentra, a Utrecht, the Netherlands-based medical device company, raised $85M in Series D funding. The round was led by Innovation Industries, with participation from Partners in Equity and Invest-NL, EQT Life Sciences and Health Innovatio... |
| 12.06.2020 | Innovative type two diabetes treatment scores $29m | An early stage non-invasive treatment for type two diabetes is set to begin human trials in Adelaide in late 2020, thanks to a $29 million cash injection from Brandon Capital’s Medical Research Commercialisation Fund and US fund Santé Ventu... |
Show more